By Najat Kantouar Oxford Instruments sees on-year revenue growth, reflecting particularly strong results in research and discovery, but expects full-year.
Exxon's all-stock acquisition of Permian Basin oil and gas specialist beats out Pfizer's $44.6 billion acquisition of Seagen in a weak year for deals thus far.
By Dean Seal Shares of Hyatt Hotels gained after the company said it will be added to the S&P MidCap 400. The stock was up 7.2% at $112 in early trading..
By Will Feuer Shares of Veralto fell on Tuesday in its second day of trading since its spin-off from the industrial conglomerate Danaher. The stock was down.
By Will Feuer Shares of recently spun-off companies, including Vestis, Veralto and W.K. Kellogg, are so far getting the cold shoulder from Wall Street..